LPCN - Lipocine Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
19M
Enterprise Value 3
9.85M
Trailing P/E
N/A
Forward P/E 1
-1.77
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
115.17
Price/Book (mrq)
1.77
Enterprise Value/Revenue 3
59.72
Enterprise Value/EBITDA 6
-0.78

Trading Information

Stock Price History

Beta (5Y Monthly) 0.16
52-Week Change 3-63.47%
S&P500 52-Week Change 325.98%
52 Week High 33.4500
52 Week Low 30.3200
50-Day Moving Average 30.3982
200-Day Moving Average 31.8042

Share Statistics

Avg Vol (3 month) 31.17M
Avg Vol (10 day) 32.41M
Shares Outstanding 535.85M
Float 23.99M
% Held by Insiders 16.06%
% Held by Institutions 119.10%
Shares Short (Dec 30, 2019) 4682.81k
Short Ratio (Dec 30, 2019) 40.82
Short % of Float (Dec 30, 2019) 42.98%
Short % of Shares Outstanding (Dec 30, 2019) 41.90%
Shares Short (prior month Nov 28, 2019) 4527.76k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-7,650.71%

Management Effectiveness

Return on Assets (ttm)-39.42%
Return on Equity (ttm)-134.33%

Income Statement

Revenue (ttm)164.99k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-4.22M
EBITDA -12.61M
Net Income Avi to Common (ttm)-12.94M
Diluted EPS (ttm)-0.5480
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)11.55M
Total Cash Per Share (mrq)0.46
Total Debt (mrq)7.94M
Total Debt/Equity (mrq)105.73
Current Ratio (mrq)3.31
Book Value Per Share (mrq)0.30

Cash Flow Statement

Operating Cash Flow (ttm)-10.59M
Levered Free Cash Flow (ttm)-6.08M